Ipsc Equipment & Supplies In Malta
79 equipment items found
Manufactured by:BrainXell based inMadison, WISCONSIN (USA)
Origin: Human iPSC line, 2M Viable Cells/Vial (BX-0200), Contents: 1 vial of cells and corresponding BrainXell, supplements, Cryopreserved. ...
Manufactured by:BrainXell based inMadison, WISCONSIN (USA)
Origin: Human iPSC line. Products: 2M Viable Cells/Vial - Standard (BX-0600). 1M Viable Cells/Vial - Standard (BX-0600e). Contents: 1 vial of cells and corresponding BrainXell supplement. ...
Manufactured by:Brooklyn ImmunoTherapeutics (BTX) based inSan Diego, CALIFORNIA (USA)
Mesenchymal stem/stromal cells (MSC) have undergone extensive clinical testing for many diseases and have consistently demonstrated safety. In addition, the immunomodulatory properties of MSC have been well characterized. However, adult-tissue-derived MSC have shown inconsistent therapeutic efficacy, significant variability among samples, and limited proliferative capacity. On the other ...
Manufactured by:Mirus Bio LLC based inMadison, WISCONSIN (USA)
A broad spectrum, low toxicity, DNA transfection reagent. ...
Manufactured by:BrainXell based inMadison, WISCONSIN (USA)
Origin: Human iPSC line. Products: 2M Viable Cells/Vial - Standard (BX-0650). 1M Viable Cells/Vial - Standard (BX-0650e). Contents: 1 vial of cells and corresponding BrainXell supplement. ...
Manufactured by:Khloris Biosciences, Inc. based inMountain View, CALIFORNIA (USA)
By developing cardiomyocytes directly from patient-derived iPSCs, we create a non-invasive, personalized platform to directly observe the effects of drug therapies on heart ...
Manufactured by:Trailhead Biosystems Inc. based inBeachwood, OHIO (USA)
We are currently developing a novel protocol that will use only small molecules to make human cortical interneurons of the forebrain from induced pluripotent stem cells (iPSCs). Our dopaminergic neurons can be used to accelerate the drug discovery process for treatments of neuropsychiatric disorders, schizophrenia, autism, and intellectual ...
Manufactured by:Trailhead Biosystems Inc. based inBeachwood, OHIO (USA)
We are developing these specialized human cells from human (non-embryo) induced pluripotent stem cells (iPSCs) using our proprietary HD-DOE™ research and development platform. We already have a nascent protocol for the generation of hypothalamic NPY-expressing cells. We believe that the delivery of specific subsets of hypothalamic cells from iPSC would be a gate-opener for the drug ...
Manufactured by:Universal Cells Inc. based inSeattle, WASHINGTON (USA)
Pluripotent stem cells (PSCs) such as embryonic stem cells (ESCs) and induced PSCs (iPSCs) are undifferentiated stem cells that can differentiate into any cell type found in the body. Scientists around the world are using PSCs to produce more mature cell types with diverse therapeutic functions. These new cell therapies have the potential to change the lives of patients suffering from diseases of ...
Manufactured by:Brooklyn ImmunoTherapeutics (BTX) based inSan Diego, CALIFORNIA (USA)
Cellular reprogramming refers to the process of transforming patient skin cells into pluripotent stem cells, called induced pluripotent stem cells (iPSC). Since 2012 Nobel Prize Winner Dr. Shinya Yamanaka's initial discovery of iPSC in 2006, iPSC availability has transformed the field of cell therapy. Brooklyn uses the fastest, highest-efficiency method for generating iPSC – a key ...
Manufactured by:Khloris Biosciences, Inc. based inMountain View, CALIFORNIA (USA)
Khloris' iPSCs are optimized to generate high-functioning cardiomyocytes, enabling development of an allogeneic source of donor cells for patients with damaged heart ...
Manufactured by:REPROCELL Inc. based inYokohama, JAPAN
RPChiPS7713G1 iPSCs reprogrammed from EPCs derived from blood ethically sourced from a Caucasian male, aged ...
Manufactured by:Khloris Biosciences, Inc. based inMountain View, CALIFORNIA (USA)
iPSC vaccination presents a differentiated approach to cancer treatment, targeting a panoply of antigens, leveraging the patient's immune system for optimized antigen presentation, and engaging both cellular and humoral ...
Manufactured by:Trailhead Biosystems Inc. based inBeachwood, OHIO (USA)
We have developed a novel three-stage protocol that uses only small molecules to make human dopaminergic neurons of the midbrain from induced pluripotent stem cells ...
Manufactured by:REPROCELL Inc. based inYokohama, JAPAN
RPChiPS8023G1 iPSCs reprogrammed from EPCs derived from blood ethically sourced from a Hispanic female, aged ...
Manufactured by:REPROCELL Inc. based inYokohama, JAPAN
Encodes the human c-Myc protein. Stemgent c-Myc mRNA encodes the c-Myc protein commonly used in cellular reprogramming systems for the generation of induced pluripotent stem (iPS) cells. This in vitro transcribed mRNA incorporates both pseudouridine and 5-methylcytidine modified nucleotides to minimize the cellular interferon response to single stranded RNA. Repeated transfection of c-Myc mRNA in ...
Manufactured by:REPROCELL Inc. based inYokohama, JAPAN
Encodes the human Oct4 protein. Stemgent Oct4 mRNA encodes the Oct4 protein commonly used in cellular reprogramming systems for the generation of induced pluripotent stem (iPS) cells. This in vitro transcribed mRNA incorporates both pseudouridine and 5-methylcytidine modified nucleotides to minimize the cellular interferon response to single stranded RNA. Repeated transfection of Oct4 mRNA in ...
Manufactured by:Sigma-Aldrich based inBellefonte, PENNSYLVANIA (USA)
3dGRO® Human Colon Organoid Expansion Medium is a complete ready-to-use serum-free medium for the expansion and long-term culture of human colonic organoids. The medium has been validated for use with 3dGRO® Human iPSC Derived Colon Organoids (Cat. No. SCC300). Colon organoids propagated in the medium express colon-specific markers including the posterior hindgut marker CDX2, a-carbonic ...
Manufactured by:Trailhead Biosystems Inc. based inBeachwood, OHIO (USA)
We are currently developing a novel protocol that will use only small molecules to make human medium spiny neurons from human (non-embryo) induced pluripotent stem cells (iPSCs). We will use our medium spiny neurons as the foundation for a cell transplantation therapy for treating Huntington’s Disease, which we are ...
Manufactured by:Trailhead Biosystems Inc. based inBeachwood, OHIO (USA)
We are developing human red blood cells (Erythrocytes) from induced pluripotent stem cells (iPSCs) in a two-step process (iPSCs to HSCs and HSCs to Erythrocytes). Our novel protocols will use small molecules to make red blood cells, which will allow production of red blood cells at scale. We will use our red blood cells as the foundation for a cell therapy for the treatment of blood loss and ...